Evidence map›Paper›PMID 38140659›Full record

ArticleViruses2023

The Role of Late Presenters in HIV-1 Transmission Clusters in Europe.

Mafalda N S Miranda, Victor Pimentel, Perpétua Gomes, Maria do Rosário O Martins, Sofia G Seabra, Rolf Kaiser, Michael Böhm, Carole Seguin-Devaux, Roger Paredes, Marina Bobkova and 4 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 6 countries.

Mafalda N S MirandaGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, New University of Lisbon (IHMT/UNL), 1349-008 Lisbon, Portugal.ORCID 0000-0002-7184-1240
Victor PimentelGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, New University of Lisbon (IHMT/UNL), 1349-008 Lisbon, Portugal.
Perpétua GomesLaboratório de Biologia Molecular (LMCBM, SPC, CHLO-HEM), 1349-019 Lisbon, Portugal.ORCID 0000-0003-3271-8255
Maria do Rosário O MartinsGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, New University of Lisbon (IHMT/UNL), 1349-008 Lisbon, Portugal.ORCID 0000-0002-7941-0285
Sofia G SeabraGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, New University of Lisbon (IHMT/UNL), 1349-008 Lisbon, Portugal.
Rolf KaiserInstitute of Virology, University Hospital of Cologne, University of Cologne, 50923 Cologne, Germany.
Michael BöhmInstitute of Virology, University Hospital of Cologne, University of Cologne, 50923 Cologne, Germany.
Carole Seguin-DevauxLaboratory of Retrovirology, Department of Infection and Immunity, Luxembourg Institute of Health, L-4354 Esch-sur-Alzette, Luxembourg.ORCID 0000-0003-0636-5222
Roger ParedesInfectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital University Hospital Germans Trias i Pujol, 08916 Badalona, Spain.
Marina BobkovaGamaleya National Research Center of Epidemiology and Microbiology, 123098 Moscow, Russia.ORCID 0000-0001-5481-8957
Maurizio ZazziDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-0344-6281
Francesca IncardonaIPRO-InformaPRO S.r.l., 00152 Rome, Italy.ORCID 0000-0002-7386-8551
Marta PingarilhoGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, New University of Lisbon (IHMT/UNL), 1349-008 Lisbon, Portugal.ORCID 0000-0002-7928-3087
Ana B AbecasisGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, New University of Lisbon (IHMT/UNL), 1349-008 Lisbon, Portugal.ORCID 0000-0002-3903-5265
University of Lisbon · PTUniversity of Cologne · DEEscola Superior de Saúde Egas Moniz · PTGamalei Institute of Epidemiology and Microbiology · RUInforma (Italy) · ITIrsiCaixa · ESLuxembourg Institute of Health · LUUniversity of Siena · IT

Funding

Fundação para a Ciência e Tecnologia COVID/BD/152613/2022Fundação para a Ciência e Tecnologia GHTM- UID/04413/2020Fundação para a Ciência e Tecnologia INTEGRIV (PTDC/SAU-INF/31990/2017)Fundação para a Ciência e Tecnologia PD/BD/135714/2018Gilead Science Génese HIVLatePresenters
6 · The paper itself

Abstract

backgroundInvestigating the role of late presenters (LPs) in HIV-1 transmission is important, as they can contribute to the onward spread of HIV-1 virus before diagnosis, when they are not aware of their HIV status.

objectiveTo characterize individuals living with HIV-1 followed up in Europe infected with subtypes A, B, and G and to compare transmission clusters (TC) in LP vs. non-late presenter (NLP) populations.

methodsInformation from a convenience sample of 2679 individuals living with HIV-1 was collected from the EuResist Integrated Database between 2008 and 2019. Maximum likelihood (ML) phylogenies were constructed using FastTree. Transmission clusters were identified using Cluster Picker. Statistical analyses were performed using R.

results2437 (91.0%) sequences were from subtype B, 168 (6.3%) from subtype A, and 74 (2.8%) from subtype G. The median age was 39 y/o (IQR: 31.0-47.0) and 85.2% of individuals were males. The main transmission route was via homosexual (MSM) contact (60.1%) and 85.0% originated from Western Europe. In total, 54.7% of individuals were classified as LPs and 41.7% of individuals were inside TCs. In subtype A, individuals in TCs were more frequently males and natives with a recent infection. For subtype B, individuals in TCs were more frequently individuals with MSM transmission route and with a recent infection. For subtype G, individuals in TCs were those with a recent infection. When analyzing cluster size, we found that LPs more frequently belonged to small clusters (<8 individuals), particularly dual clusters (2 individuals).

conclusionLP individuals are more present either outside or in small clusters, indicating a limited role of late presentation to HIV-1 transmission.

Indexed as

HIV-1HIV InfectionsHIV SeropositivitySexual and Gender MinoritiesAdultCluster AnalysisEuropeFemaleHomosexuality, MaleHumansLipopolysaccharidesMalePhylogenyLipopolysaccharidesHIV-1 infectionlate presentersnon-late presenterstransmission clusters

Identifiers

PMID38140659
PMCPMC10746990
OpenAlexW4389673293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.